Community Practice Connections™: Leveraging Immunogenicity in Women's Cancers: The Experts Weigh in on Current Evidence and Practical Guidance in Cervical and Endometrial Cancers

Community Practice Connections™: Leveraging Immunogenicity in Women's Cancers: The Experts Weigh in on Current Evidence and Practical Guidance in Cervical and Endometrial Cancers is organized by Physicians' Education Resource, LLC (PER).

Release Date: August 30, 2019
Expiration Date: August 30, 2020

Target Audience:
This educational program is directed toward medical oncologists, pathologists, radiation oncologists, and surgical oncologists who treat and/or manage patients with endometrial and cervical cancers. Obstetrician/gynecologists, nurses, physician assistants, fellows, and residents with an interest in endometrial and cervical cancers are also invited to participate.

Accreditation/Credit Designation:
Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Overview:
Although cervical and endometrial cancers are associated with high rates of positive clinical outcomes when detected early enough, many cases are not detected until they have reached an advanced stage. The management of patients with advanced/metastatic disease remains an important clinical challenge. Pursuit of treatment options that may help to improve clinical efficacy and limit treatment-associated adverse events is an active area of investigation, with several options showing promise in recent studies. An understanding of the mechanisms underlying the development of these diseases has helped to inform new approaches to clinical management, which may improve outcomes for your patients. The optimal utilization of deficient mismatch repair/microsatellite instability assessment and other molecular testing may also improve the integration of new treatment options into clinical practice.

Keeping up with these advancements can be a challenging goal for busy clinicians, as can development of a thorough understanding of potential applications of new data from trials evaluating therapeutic approaches for advanced cervical and endometrial cancers. This interactive, online activity is designed to help clinicians achieve this. It is based on a live symposium held adjunct to the 2019 annual oncology meeting in Chicago. Through a series of brief video interviews, the multidisciplinary faculty—comprising renowned experts in gynecologic oncology and immunotherapy—review practice-changing data and their impact on patient care, discuss “real-world” clinical cases, and share forward-looking perspectives on the treatment horizon.

Learning Objectives:
Upon successful completion of this educational activity, you should be better prepared to:
• Assess the current role of biomarkers to guide the potential application of immunotherapy for endometrial and cervical cancer.
• Describe key safety and efficacy data regarding immunotherapies for patients with endometrial and cervical cancer.
• Appraise current and emerging treatment combinations involving immunotherapy for women’s cancers.
• Outline evidence-based approaches to mitigate adverse events associated with immunotherapy for patients with endometrial and cervical cancer.

Additional details will be posted as soon as information is available.